Search results
Results from the WOW.Com Content Network
Status epilepticus (SE), or status seizure, is a medical condition with abnormally prolonged seizures, and which can have long-term consequences [3], manifesting as a single seizure lasting more than a defined time (time point 1), or 2 or more seizures over the same period without the person returning to normal between them.
In the United States, cenobamate is indicated for the treatment of partial-onset seizures in adults. [3]In the European Union, it is indicated for the adjunctive treatment of focal-onset seizures with or without secondary generalization in adults with epilepsy who have not been adequately controlled despite a history of treatment with at least two anti-epileptic medications.
The definition of epilepsy requires the occurrence of at least one epileptic seizure." [12] [107] It is, therefore, possible to outgrow epilepsy or to undergo treatment that causes epilepsy to be resolved, but with no guarantee that it will not return. In the definition, epilepsy is now called a disease, rather than a disorder.
[3] [5] It also includes those who have had more than one unprovoked seizure more than 24 hours apart. [3] [59] It is recommended to start with one anti-seizure medication. [5] [59] Another may be added if one is not enough to control the seizure occurrence. [59] Approximately 70% of people can obtain full control with continuous use of ...
Therefore, almost all new epilepsy drugs are initially approved only as adjunctive (add-on) therapies. Patients whose epilepsy is uncontrolled by their medication (i.e., it is refractory to treatment) are selected to see if supplementing the medication with the new drug leads to an improvement in seizure control.
About one-third of people who have mild ... “AGB101 is a once-a-day tablet formulation of an anti-seizure medication that quiets this hyperactivity in the brain and brings it down to levels we ...
Levetiracetam, sold under the brand name Keppra among others, is a novel antiepileptic drug [7] used to treat epilepsy. [8] It is used for partial-onset, myoclonic, or tonic–clonic seizures, [7] and is taken either by mouth as an immediate or extended release formulation or by injection into a vein. [8]
Eslicarbazepine acetate (ESL), sold under the brand names Aptiom and Zebinix among others, is an anticonvulsant medication approved for use in Europe and the United States as monotherapy or as additional therapy for partial-onset seizures epilepsy. [6] [4] [3] Similarly to oxcarbazepine, ESL behaves as a prodrug to (S)-(+)-licarbazepine. [7]